Video

Psychedelic Wellness

Author(s):

Early studies find psilocybin shows promise for some psychiatric disorders...

With numerous studies in stage 3 trials, the opportunities to leverage psilocybin for clinical care is likely to expand in the next few years. Matt Stang shares his excitement for the future of this agent as means to help more patients.

To learn more on psilocybin and earn CME credit, see Psilocybin Revisited: The Science Behind the Drug and Its Surprising Therapeutic Potential.

Mr Stang is the founder of Delic Corp.

Newsletter

Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients.

Related Videos
Psychiatric Times Experts Weight in on FDA Advisory Decision for PTSD
ketamine
New Africa /Adobestock
Tasphong/AdobeStock
Andrii Yalaanskyi/AdobeStock
Jorm Sangsorn/AdobeStock
RolfImages/AdobeStock
CravenA/AdobeStock
brain
© 2025 MJH Life Sciences

All rights reserved.